Stockreport

Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients

Annovis Bio, Inc.  (ANVS) 
PDF Enrollment will begin in January 2026 Participants will be treated with buntanetap for 36 months The study aims to enroll 500 patients MALVERN, Pa., Dec. 18, 2025 ( [Read more]